Skip to content
- EOSE: Revenue Growth Faces the Gross-Margin Test Ahead of November 5 Earnings
- OCGN: Clinical Milestones and Cash Runway Put the Pipeline Ahead of the Earnings Headline
- HPAI: A 300-Unit AI Deployment Target Meets a Late-Filing Warning
- XMAX: A $30 Million Buyback Authorization Meets a Weaker Sales Picture
- CMTG: Loan Resolutions and Lower Debt Put a Troubled Mortgage Portfolio in Focus
- STIM: Revenue Growth and Positive Adjusted EBITDA Give the Rally Substance
- IMNN: ThermoDox Deal Gives a Written-Off Asset a New Path
- KTTA: Pasithea Approaches Its October 23 Cancer-Data Presentation
- SHFS: Nasdaq Gives Safe Harbor More Time as Shares Rebound
- NUAI: New Era’s AI Data-Center Plan Faces the Tenant Test
